Beta-blocker therapy stands as a cornerstone in the realm of cardiovascular medicine, offering a multifaceted approach to address various conditions. These pharmacological agents, commonly known as beta-blockers, exert their therapeutic effects by antagonizing the impact of adrenaline, resulting in a reduction of heart rate and blood pressure. Widely prescribed to manage hypertension, angina, and specific cardiac arrhythmias, beta-blockers showcase their effectiveness in diverse cardiovascular scenarios. Notably, their role extends to the management of heart failure, where they contribute to enhancing cardiac function and alleviating symptoms. Post-myocardial infarction care also heavily relies on beta-blocker therapy to prevent subsequent cardiovascular events. Beyond cardiovascular applications, these agents demonstrate versatility, occasionally finding use in mitigating symptoms associated with anxiety and migraine headaches. While generally well-tolerated, the individualized consideration of medical histories and potential contraindications is imperative in the prescription of beta-blocker therapy. A collaborative approach between healthcare providers and patients remains paramount to ensuring optimal cardiovascular health management.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom